Immunotherapy with Subcutaneous Injection of Immunomodulatory Agent (OK-432) Elicits Durable Response in Locally Advanced or Relapsed Cervical Cancer

Immunotherapy (IT) has been studied as a new and alternative treatment option for locally advanced, persistent, recurrent, or relapsed cervical cancer in an effort to extend the life and possibly cure patients with advanced stage disease. Targeted immune checkpoint inhibitors augment anticancer immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alas, Quenny Michelle Dyan A., Lin, Cheng-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515755/
https://www.ncbi.nlm.nih.gov/pubmed/31143629
http://dx.doi.org/10.4103/GMIT.GMIT_1_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515755/
https://www.ncbi.nlm.nih.gov/pubmed/31143629
http://dx.doi.org/10.4103/GMIT.GMIT_1_19

Ejemplares similares